Know Cancer

or
forgot password

Including Patient Preferences in Symptom Management of Cancer Patients: A Randomized Clinical Trial


N/A
18 Years
N/A
Not Enrolling
Both
Cancer, Lymphoma, Leukemia, Stem Cell Transplantation

Thank you

Trial Information

Including Patient Preferences in Symptom Management of Cancer Patients: A Randomized Clinical Trial


as above


Inclusion Criteria:



- Starting treatment for a newly diagnosed acute myelogenous leukemia (AML), lymphatic
leukemia (ALL), Hodgkin or non-Hodgkin lymphoma, or

- starting treatment for a recurrence of the disease;

- starting treatment with allogenous or autologous Stem Cell Transplantation (SCT).

- above 18 years of age.

Exclusion Criteria:

- having received radiation on the brain

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care

Outcome Measure:

Physicians' and nurses' symptom-related chart entries in patients' records

Outcome Time Frame:

In-patient episodes of care

Safety Issue:

No

Principal Investigator

Cornelia M Ruland, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Rikshospitalet-Radiumhospitalet

Authority:

Norway:National Committee for Medical and Health Research Ethics

Study ID:

RCN 154739/320

NCT ID:

NCT00709813

Start Date:

December 2003

Completion Date:

December 2005

Related Keywords:

  • Cancer
  • Lymphoma
  • Leukemia
  • Stem Cell Transplantation
  • Symptom management
  • Cancer
  • Patient-centered care
  • Leukemia
  • Lymphoma

Name

Location